Merit Medical (MMSI) Q1 FY26 earnings call

Merit Medical delivered a strong Q1 FY26, surpassing revenue and EPS expectations, driven by solid organic growth and contributions from recent acquisitions. The company strategically expanded its oncology platform with the acquisition of View Point Medical, significantly broadening its addressable market. Despite headwinds in OEM sales and tariff impacts, management reaffirmed its full-year guidance, confident in its continued growth initiatives and disciplined operational execution.